Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.

@article{Shariat2005NomogramsIN,
  title={Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.},
  author={Shahrokh F Shariat and Craig R Zippe and Gerson Luedecke and Hans Boman and Marta S{\'a}nchez-Carbayo and Roberto Casella and Christine Mian and Martin G. Friedrich and Sanaa Eissa and Hideyuki Akaza and Ihor S. Sawczuk and Vincenzo Serretta and Hartwig Huland and Hans H Hedelin and Raina Rupesh and Naoto Miyanaga and Arthur I. Sagalowsky and Frank Wians and Claus G. Roehrborn and Yair Lotan and Paul Perrotte and Serge Benayoun and Michael J Marberger and Pierre I. Karakiewicz},
  journal={The Journal of urology},
  year={2005},
  volume={173 5},
  pages={1518-25}
}
PURPOSE We developed and validated nomograms that accurately predict disease recurrence and progression in patients with Ta, T1, or CIS transitional cell carcinoma (TCC) of the bladder using a large international cohort. METHODS Univariate and multivariate logistic regression models targeted histologically confirmed disease recurrence, and focused on 2,542 patients with bladder TCC from 10 participating centers. Variables consisted of pre-cystoscopy voided urine Nuclear Matrix Protein 22… CONTINUE READING